HPV for Cervical Cancer Screening: Is the Era of the Molecular Pap Smear Upon Us?Mark H. Stoleraa University of Virginia Health System, Charlottesville, Virginia Correspondence to: Mark H. Stoler, Pathology, University of Virginia Health System, Jefferson Park Ave., OMS Room 3880, PO Box 800214, Charlottesville, VA 22908.
Based on the best estimates of the prevalence of human Papillomavirus infection in the United States, the overall HPV prevalence in the target population is approximately 20%. The prevalence varies greatly with age, being as high as (J Histochem Cytochem 49:11971198, 2001) Key Words: human, Papillomavirus, screening, cervical neoplasia, Pap smear
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||